 | • レポートコード：TPM-B04417 • 出版社/出版日：Transparency Market Research / 2018年2月 • レポート形態：英文、PDF、218ページ • 納品方法：Eメール • 産業分類：製薬・医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、癌性悪液質の世界市場について調べ、癌性悪液質の世界規模、市場動向、市場環境、治療方法別分析、作用機序別分析、流通経路別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、供給・需要シナリオ、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・癌性悪液質の世界市場動向 ・癌性悪液質の世界市場環境 ・癌性悪液質の供給・需要シナリオ ・癌性悪液質の世界市場規模 ・癌性悪液質の世界市場規模：治療方法別 ・癌性悪液質の世界市場規模：作用機序別 ・癌性悪液質の世界市場規模：流通経路別 ・癌性悪液質の世界市場：地域別市場規模・分析 ・癌性悪液質の北米市場規模・予測 ・癌性悪液質のアメリカ市場規模・予測 ・癌性悪液質の中南米市場規模・予測 ・癌性悪液質のヨーロッパ市場規模・予測 ・癌性悪液質のアジア市場規模・予測 ・癌性悪液質の日本市場規模・予測 ・癌性悪液質の中国市場規模・予測 ・癌性悪液質のインド市場規模・予測 ・癌性悪液質の中東市場規模・予測 ・癌性悪液質のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Cancer Cachexia Market: Overview
This report on the cancer cachexia market analyzes the current and future scenario of the global market. Growth of the global cancer cachexia market is driven by high investments made in cutting-edge drug research resulting in new, sophisticated treatments with specific mechanism of action. Moreover, rising emphasis on palliative cancer care will further boost the market in near future. The cancer cachexia market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market.
It also provides information and data analysis of the global market with respect to the segments based on therapeutics, mechanism of action, distribution channel, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the cancer cachexia market.
Global Cancer Cachexia Market: Segmentation
The global cancer cachexia market has been analyzed on the basis of therapeutics, mechanism of action, distribution channels and geography. Major therapeutics segments are progestogens, corticosteroids combination therapies, others. The others segment of global cancer cachexia market includes pipeline therapeutic approach. Thus the market of others segment has been considered as addressable market. According to mechanism of action, market is segmented in to appetite stimulators, weight loss stabilizers, and other mode of actions. Hospital stores, retail pharmacy stores, online pharmacy are considered as preferred distribution channels.
The market is driven by argumentative lifestyle habits leading to lung cancer, rising incidence rate of cachexia mainly in the developed region like the U.S., Europe and Japan. Moreover, increasing funding for cancer research by government and private organizations, increased awareness about palliative care will further the demand for cancer cachexia drugs in near future. While, stringent regulatory requirements and long procedure for FDA approval have discouraged cancer cachexia drug manufacturers. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
Global Cancer Cachexia Market: Regional Outlook
Geographically, the global cancer cachexia market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in Report
The report also profiles major players in the global cancer cachexia market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players in the women’s health market are – Æterna Zentaris Inc., Alder BioPharmaceuticals Inc., Aphios Corporation, Eli Lilly and Company, GTx, Inc., Helsinn Group, Merck & Co., Inc., Novartis AG, Bristol-Myers Squibb Company, and XBiotech, Inc.
The global cancer cachexia market has been segmented as follows:
By Therapeutics
Progestogens
Corticosteroids
Combination Therapies
Others
By Mechanism of action
Appetite Stimulators
Weight Loss Stabilizers
Others
By Distribution Channel
Hospital Stores
Retail Pharmacy Stores
Online Pharmacy
By Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia and New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of MEA
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
2. Assumptions and Research Methodology
3. Executive Summary: Global Cancer Cachexia Market
4. Market Overview
4.1. Introduction
4.1.1. Therapeutics Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.5. Global Cancer Cachexia Market Analysis and Forecasts, 2014-2024
4.5.1. Market Revenue Projections (US$ Mn)
4.6. Cancer Cachexia Market – Global Supply Demand Scenario
4.7. Porter’s Five Force Analysis
4.8. Regulatory Scenario
4.9. Cancer Cachexia – Incidence Rate
4.10. Cancer Cachexia – Therapeutic Approach
4.11. Cancer Cachexia Market: Pipeline Analysis
4.11.1. Phase III drugs (Forecast from approval year to 2024)
4.11.2. Phase I and Phase II drugs (Qualitative Information)
5. Global Cancer Cachexia Market Analysis and Forecasts, By Therapeutics
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Forecast by Therapeutics, 2015–2025
5.4.1. Progestogens
5.4.2. Corticosteroids
5.4.3. Combination therapies
5.5. Market Attractiveness by Therapeutics
6. Global Cancer Cachexia Market Analysis and Forecasts, By Mechanism of action
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Value Forecast by Mechanism of action, 2015–2025
6.4.1. Appetite Stimulators
6.4.2. Weight loss stabilizers
6.4.3. Others
6.5. Market Attractiveness by Mechanism of action
7. Global Cancer Cachexia Market Analysis and Forecasts, By Distribution Channels
7.1. Introduction & Definition
7.3. Key Trends
7.4. Market Value Forecast by Distribution Channels, 2015–2025
7.4.1. Hospital Stores
7.4.2. Retails Pharmacy Store
7.4.3. Online Pharmacy
7.5. Market Attractiveness by Distribution Channels
8. Global Cancer Cachexia Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Policies and Regulations
8.3. Market Value Forecast by Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East and Africa
8.4. Market Attractiveness by Country/Region
9. North America Cancer Cachexia Market Analysis and Forecast
9.1. Introduction
9.1.2. Policies and Regulations
9.1.3. Key Trends
9.2. Market Value Forecast by Therapeutics, 2015–2025
9.2.1. Progestogens
9.2.2. Corticosteroids
9.2.3. Combination therapies
9.3. Market Value Forecast by Mechanism of action, 2015–2025
9.3.1. Appetite Stimulators
9.3.2. Weight loss stabilizers
9.3.3. Others
9.4. Market Value Forecast by Distribution Channels,
9.4.1. Hospital Stores
9.4.2. Retails Pharmacy Store
9.4.3. Online Pharmacy
9.5. Market Value Forecast by Country, 2015–2025
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Therapeutics
9.6.2. By Mechanism of action
9.6.3. By Distribution Channels
9.6.4. By Country
10. Europe Cancer Cachexia Market Analysis and Forecast
10.1. Introduction
10.1.2. Policies and Regulations
10.1.3. Key Trends
10.2. Market Value Forecast by Therapeutics, 2015–2025
10.2.1. Progestogens
10.2.2. Corticosteroids
10.2.3. Combination therapies
10.3. Market Value Forecast by Mechanism of action, 2015–2025
10.3.1. Appetite Stimulators
10.3.2. Weight loss stabilizers
10.3.3. Others
10.4. Market Value Forecast by Distribution Channels,
10.4.1. Hospital Stores
10.4.2. Retails Pharmacy Store
10.4.3. Online Pharmacy
10.5. Market Value Forecast by Country, 2015–2025
10.5.1. U.K.
10.5.2. Germany
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Russia
10.5.7. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Therapeutics
10.6.2. By Mechanism of action
10.6.3. By Distribution Channels
10.6.4. By Country
11. Asia-Pacific Cancer Cachexia Market Analysis and Forecast
11.1. Introduction
11.1.1. Policies and Regulations
11.1.2. Key Trends
11.2. Market Value Forecast by Therapeutics, 2015–2025
11.2.1. Progestogens
11.2.2. Corticosteroids
11.2.3. Combination therapies
11.3. Market Value Forecast by Mechanism of action, 2015–2025
11.3.1. Appetite Stimulators
11.3.2. Weight loss stabilizers
11.3.3. Others
11.4. Market Value Forecast by Distribution Channels,
11.4.1. Hospital Stores
11.4.2. Retails Pharmacy Store
11.4.3. Online Pharmacy
11.5. Market Value Forecast by Country, 2015–2025
11.5.1. India
11.5.2. China
11.5.3. Japan
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia-Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Therapeutics
11.6.2. By Mechanism of action
11.6.3. By Distribution Channels
11.6.4. By Country
12. Latin America Cancer Cachexia Market Analysis and Forecast
12.1. Introduction
12.1.2. Policies and Regulations
12.1.3. Key Trends
12.2. Market Value Forecast by Therapeutics, 2015–2025
12.2.1. Progestogens
12.2.2. Corticosteroids
12.2.3. Combination therapies
12.3. Market Value Forecast by Mechanism of action, 2015–2025
12.3.1. Appetite Stimulators
12.3.2. Weight loss stabilizers
12.3.3. Others
12.4. Market Value Forecast by Distribution Channels,
12.4.1. Hospital Stores
12.4.2. Retails Pharmacy Store
12.4.3. Online Pharmacy
12.5. Market Value Forecast by Country, 2015–2025
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Therapeutics
12.6.2. By Mechanism of action
12.6.3. By Distribution Channels
12.6.4. By Country
13. Middle East and Africa Cancer Cachexia Market Analysis and Forecast
13.1. Introduction
13.1.2. Policies and Regulations
13.1.3. Key Trends
13.2. Market Value Forecast by Therapeutics, 2015–2025
13.2.1. Progestogens
13.2.2. Corticosteroids
13.2.3. Combination therapies
13.2.4. Others
13.3. Market Value Forecast by Mechanism of action, 2015–2025
13.3.1. Appetite Stimulators
13.3.2. Weight loss stabilizers
13.3.3. Others
13.4. Market Value Forecast by Distribution Channels,
13.4.1. Hospital Stores
13.4.2. Retails Pharmacy Store
13.4.3. Online Pharmacy
13.5. Market Value Forecast by Country, 2015–2025
13.5.1. South Africa
13.5.2. GCC Countries
13.5.3. Rest of Middle East and Africa
13.6. Market Attractiveness Analysis
13.6.1. By Therapeutics
13.6.2. By Mechanism of action
13.6.3. By Distribution Channels
13.6.4. By Country
14. Competition Landscape
14.1. Market Competition Analysis by Company (2016)
14.2. Company Profiles
14.2.1. Æterna Zentaris Inc.
14.2.1.1. Overview (HQ, Employee Strength, Business Segments)
14.2.1.2. Financials
14.2.1.3. Recent Development
14.2.1.4. Strategy
14.2.2. Alder BioPharmaceuticals Inc.
14.2.2.1. Overview (HQ, Employee Strength, Business Segments)
14.2.2.2. Financials
14.2.2.3. Recent Development
14.2.2.4. Strategy
14.2.3. Aphios Corporation
14.2.3.1. Overview (HQ, Employee Strength, Business Segments)
14.2.3.2. Financials
14.2.3.3. Recent Development
14.2.3.4. Strategy
14.2.4. Eli Lilly and Company
14.2.4.1. Overview (HQ, Employee Strength, Business Segments)
14.2.4.2. Financials
14.2.4.3. Recent Development
14.2.4.4. Strategy
14.2.5. GTx, Inc.
14.2.5.1. Overview (HQ, Employee Strength, Business Segments)
14.2.5.2. Financials
14.2.5.3. Recent Development
14.2.5.4. Strategy
14.2.6. Helsinn Group
14.2.6.1. Overview (HQ, Employee Strength, Business Segments)
14.2.6.2. Financials
14.2.6.3. Recent Development
14.2.6.4. Strategy
14.2.7. Merck & Co., Inc.
14.2.7.1. Overview (HQ, Employee Strength, Business Segments)
14.2.7.2. Financials
14.2.7.3. Recent Development
14.2.7.4. Strategy
14.2.8. Novartis AG
14.2.8.1. Overview (HQ, Employee Strength, Business Segments)
14.2.8.2. Financials
14.2.8.3. Recent Development
14.2.8.4. Strategy
14.2.9. Bristol-Myers Squibb Company
14.2.9.1. Overview (HQ, Employee Strength, Business Segments)
14.2.9.2. Financials
14.2.9.3. Recent Development
14.2.9.4. Strategy
14.2.10. XBiotech, Inc.
14.2.10.1. Overview (HQ, Employee Strength, Business Segments)
14.2.10.2. Financials
14.2.10.3. Recent Development
14.2.10.4. Strategy
Table 01: Global Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 02: Global Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
Table 03: Global Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 04: Global Cancer Cachexia Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 06: North America Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 07: North America Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
Table 08: North America Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 09: Europe Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 10: Europe Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 11: Europe Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
Table 12: Europe Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 13: Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 14: Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 15: Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
Table 16: Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 17: Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 18: Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 19: Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
Table 20: Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 21: Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 22: Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 23: Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
Table 24: Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025